(Source: Business Wire)

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: National Semiconductor Corp (NYSE: NSM), Cosi Inc. (NASDAQ: COSI), Jamba Inc. (NASDAQ: JMBA), Freddie Mac (NYSE: FRE) and St. Jude Medical (NYSE: STJ).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579
Here are highlights from Thursday's Analyst Blog:
Nat'l Semiconductor Kept a Buy
National Semiconductor Corp (NYSE: NSM) is an OEM [original equipment manufacturer] of analog and mixed signal integrated circuits. February quarter results beat consensus expectations, on both the top and bottom lines.
Forward guidance is for a revenue decline of 5-10% in the next quarter. New higher-margin products continue to grow in the mix, and management has refocused R&D into areas that should sustain margins.
Are Cosi & Jamba Going Extinct?
Negative cash flow and a threadbare balance sheet makes survival challenging for some restaurant operators.
As the recession deepens, cash flow tumbles and credit tightens, the restaurant industry is right-sizing excess capacity that was added to satiate shareholders' thirst for growth.
Virtually every operator has closed under-performing restaurants built in sub-par locations -- as competition for the "A" spots intensified -- while they dramatically scaled back expansion plans.
Some restaurant chains -- those that rapidly expanded despite sub-par profitability -- face extinction. Cosi Inc (NASDAQ: COSI) and Jamba Inc (NASDAQ: JMBA) are 2 such examples.
Freddie to Treasury: "More, Please"
Yesterday, after market close, Freddie Mac (NYSE: FRE) reported its 4Q08 and FY08 financial results. During the quarter, the company had a net loss (available to the common shareholders) of $23.9 billion or $7.37 per diluted share.
The huge increase in loss was driven primarily by net mark-to-market declines on the company's derivative portfolio, guarantee assets and trading securities. Increased credit-related expenses, security impairments and additional valuation allowance against its deferred tax assets were also the major contributors to the increased loss.
St. Jude Medical a Buy to $40
St. Jude Medical (NYSE: STJ) is a leading medical device manufacturer producing consistent double-digit revenue and earnings growth over the past decade.